Sigma-Aldrich acquires Cerilliant

Monday, 10 January, 2011

Sigma-Aldrich has acquired all outstanding shares of Cerilliant of Round Rock, Texas to strengthen the company’s analytical chemistry product portfolio and to continue to deliver on its strategic growth plans.

Cerilliant, a supplier of high-quality reference standards and materials, provides products that support the clinical diagnostics, environmental, nutraceutical, pharmaceutical, forensic and clinical toxicology markets.

The company expects this acquisition to be neutral to mildly accretive to earnings per share in 2011. Cerilliant has been a portfolio company of Argenta Partners of Dallas, Texas, for the past 10 years.

Cerilliant brings to Sigma-Aldrich around 2800 products and 30 years of expertise in the design, development, synthesis, characterisation and packaging of analytical standards, calibrators, controls and certified reference materials that are used in a wide range of analytical applications.

Related News

Jian Zhou Medal recognises anaesthesia, blood pressure research

The Australian Academy of Health and Medical Sciences has announced Professor Britta Regli-von...

Australian among 2025 Nobel Prize winners

The first of the 2025 Nobel Prizes have been announced — and this year's awards...

ATSE elects its next President, 2025 Fellows

The Australian Academy of Technological Sciences and Engineering (ATSE) has elected 35 new...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd